Literature DB >> 16839650

The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.

Rebecca Jane Cox1, Arnt-Ove Hovden, Karl Albert Brokstad, Ewa Szyszko, Abdullah Sami Madhun, Lars Reinhardt Haaheim.   

Abstract

Recently the urgency of developing a pandemic influenza vaccine has lead to the re-evaluation of the use of whole virus vaccine. We have compared the humoral immune response and the protective efficacy of whole and split influenza virus vaccines in mice. Whole virus vaccine was more immunogenic particularly after the first dose of vaccine, generally eliciting higher numbers of systemic antibody secreting cells and an earlier and higher neutralising antibody response. Immunisation with one dose of whole virus vaccine more effectively reduced viral shedding upon non-lethal homologous viral challenge, but two doses of split virus vaccine was most effective at limiting viral replication and this was correlated with high influenza specific serum IgG concentrations. The two vaccine formulations induced different T helper profiles particularly after one dose of vaccine; split virus vaccine induced a type 2 bias response, whereas whole virus vaccine elicited a dominant type 1 response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839650     DOI: 10.1016/j.vaccine.2006.05.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1).

Authors:  Julie M Belanger; Yossef Raviv; Mathias Viard; M Jason de la Cruz; Kunio Nagashima; Robert Blumenthal
Journal:  Virology       Date:  2011-07-02       Impact factor: 3.616

2.  Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

Authors:  Min-Chul Kim; Yu-Na Lee; Eun-Ju Ko; Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Jae-Min Song; Byung-Min Song; Youn-Jeong Lee; Jun-Gu Choi; Hyun-Mi Kang; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

3.  Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Authors:  Mariana Baz; Mukesh Samant; Hakima Zekki; Pascale Tribout-Jover; Martin Plante; Anne-Marie Lanteigne; Marie-Eve Hamelin; Corey Mallett; Barbara Papadopoulou; Guy Boivin
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

4.  Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.

Authors:  Brendon Y Chua; Toshiki Sekiya; Marios Koutsakos; Naoki Nomura; Louise C Rowntree; Thi H O Nguyen; Hayley A McQuilten; Marumi Ohno; Yuki Ohara; Tomohiro Nishimura; Masafumi Endo; Yasushi Itoh; Jennifer R Habel; Kevin J Selva; Adam K Wheatley; Bruce D Wines; P Mark Hogarth; Stephen J Kent; Amy W Chung; David C Jackson; Lorena E Brown; Masashi Shingai; Katherine Kedzierska; Hiroshi Kida
Journal:  PLoS Pathog       Date:  2022-10-07       Impact factor: 7.464

5.  Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 6.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

7.  Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.

Authors:  Yu-Na Lee; Hye Suk Hwang; Min-Chul Kim; Young-Tae Lee; Yu-Jin Kim; F Eun-Hyung Lee; Sang-Moo Kang
Journal:  Nanomedicine       Date:  2015-12-02       Impact factor: 5.307

8.  Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice.

Authors:  Jian Chen; Lin Yuan; Qing Fan; Fei Su; Yu Chen; Songhua Hu
Journal:  BMC Immunol       Date:  2012-07-07       Impact factor: 3.615

9.  Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Authors:  Alexandra S Gambaryan; Natalia F Lomakina; Elizaveta Y Boravleva; Ekaterina A Kropotkina; Vadim V Mashin; Igor V Krasilnikov; Alexander I Klimov; Larisa G Rudenko
Journal:  Influenza Other Respir Viruses       Date:  2011-09-23       Impact factor: 4.380

10.  Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.

Authors:  Katja Höschler; Robin Gopal; Nick Andrews; Melanie Saville; Stephanie Pepin; John Wood; Maria C Zambon
Journal:  Influenza Other Respir Viruses       Date:  2007 Sep-Nov       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.